Matthew Ferguson - 10 May 2021 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Ronald Lloyd, Attorney-in-fact for Matthew Ferguson
Issuer symbol: ELUT
Transactions as of: 10 May 2021
Net transactions value: +$25,482
Form type: 4
Filing time: 12 May 2021, 18:01:12 UTC
Next filing: 10 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AZYO	Class A Common Stock	Purchase	$14,482	+1,300		$11.14	1,300	10 May 2021	Direct	F1
transaction	AZYO	Class A Common Stock	Purchase	$11,000	+1,000	+77%	$11.00	2,300	11 May 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.97 to $11.21. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.97 to $11.21. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.